You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ropeginterferon

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Taipei (Ropeginterferon alfa-2b, SOC)

Not yet recruiting
  • COVID-19
  • Ropeginterferon alfa-2b
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 9, 2023

COVID-19 Trial in Taipei (P1101 (Ropeginterferon alfa-2b), SOC)

Active, not recruiting
  • COVID-19
  • P1101 (Ropeginterferon alfa-2b)
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Mar 13, 2023

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Essential Thrombocythemia
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib, Ropeginterferon)

Recruiting
  • Chronic Myeloid Leukemia
  • Aalborg, Denmark
  • +17 more
Apr 4, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Not yet recruiting
  • Polycythemia Vera (PV)
  • Mie, Japan
  • +5 more
Aug 15, 2023

Hepatitis D Trial in Taipei (Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide)

Not yet recruiting
  • Hepatitis D
  • Ursodeoxycholic acid
  • +2 more
  • Taipei, Taiwan
  • +1 more
Jul 19, 2022

Chronic Hepatitis B Infection, Chronic Hepatitis D Infection Trial in Taipei City, Taipei city, Taoyuan city (P1101 + Nivolumab

Recruiting
  • Chronic Hepatitis B Infection
  • Chronic Hepatitis D Infection
  • P1101 + Nivolumab + Entecavir
  • Taipei City, Taiwan
  • +3 more
Sep 15, 2021

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Hepatocellular Carcinoma Trial in Taipei city (P1101 (Ropeginterferon alfa-2b), Nivolumab)

Recruiting
  • Hepatocellular Carcinoma
  • Taipei city, Taiwan
    National Taiwan university Hospital
Jan 25, 2022

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

Recruiting
  • Polycythemia Vera (PV)
  • P1101 (Ropeginterferon alfa-2b)
  • Toon-shi, Ehime, Japan
  • +5 more
Jun 13, 2022

Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

Active, not recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b
  • Beijing, China
  • +13 more
Aug 1, 2022

Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • P1101 + Ribavirin
  • PEG-Intron + Ribavirin
  • Beijing, China
  • +38 more
Jan 14, 2022

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Completed
  • Polycythemia Vera (PV)
  • Toon-shi, Ehime, Japan
  • +7 more
Dec 8, 2021

Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

Recruiting
  • Essential Thrombocythemia
  • Phoenix, Arizona
  • +60 more
Dec 30, 2021

Healthy Volunteers Trial in Melbourne (ropeginterferon alfa-2b)

Completed
  • Healthy Volunteers
  • ropeginterferon alfa-2b
  • Melbourne, Victoria, Australia
    Nucleus Network Limited
Nov 22, 2019

Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

Completed
  • Hepatitis C, Chronic
  • PEGASYS 180 µg Q1W
  • +3 more
  • Changhua, Taiwan
  • +12 more
Oct 7, 2021

Action of Interferon in Treatment of Myeloproliferative

Recruiting
  • Myeloproliferative Neoplasm
    • Villejuif, Ile De France, France
      Inserm U1287
    Apr 28, 2023

    Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

    Active, not recruiting
    • Polycythemia Vera
    • San Giovanni Rotondo, (FG) Puglia, Italy
    • +22 more
    Jan 10, 2023